Industry News

Our news page will keep you informed of press releases and news articles on rapid and alternative microbiological method technologies and updates from technology suppliers.

Please click here to submit your news.

Idaho Technology to Highlight Diagnostic FilmArray® Respiratory Panel at 28th Annual Clinical Virology Symposium

Idaho Technology, Inc., a privately held clinical diagnostics company dedicated to providing the world's fastest, highest-quality instruments for pathogen identification and DNA analysis, today announced several posters will be presented highlighting its FilmArray® Respiratory Panel (FilmArray RP), a user-friendly Multiplex pathogen detection system, at the 28th Annual Clinical Virology Symposium and Annual Meeting of the Pan American Society for Clinical Virology, held April 22 - 25, 2012, in Daytona Beach, FL.

In addition, the Company will showcase its FilmArray diagnostic platform at booth #233, where Idaho Technology representatives will be available to discuss FilmArray benefits and potential clinical applications.

FilmArray RP is Idaho Technology's first clinical diagnostic test designed to run on the Company's novel FilmArray system, which represents a significant advancement in user-friendliness and multiplex infectious disease testing capability for hospital clinical labs. FilmArray RP rapidly detects nucleic acids in nasopharyngeal swabs obtained from individuals suspected of respiratory tract infections. Requiring only two minutes of hands-on time, FilmArray RP has about a 1-hour turnaround time, and simultaneously tests for the following panel of respiratory pathogens: Adenovirus, Coronavirus HKU1, Coronavirus NL63, Human Metapneumovirus, Influenza A, Influenza A subtype H1, Influenza A subtype H3, Influenza A subtype H1 2009, Influenza B, Parainfluenza virus 1, Parainfluenza virus 2, Parainfluenza virus 3, Parainfluenza virus 4, Rhinovirus/Enterovirus, and Respiratory Syncytial Virus.

FilmArray RP is available for use by hospital and clinical laboratory professionals in the United States and Europe, and has received FDA-clearance for a panel of the above 15 targets and CE IVD registration for a panel of 21 targets. An expanded respiratory panel, which will include five additional bacterial and viral targets, is currently under review by the FDA. Idaho Technology is continuing to develop a broader test menu for its FilmArray system, including a blood culture ID panel, gastrointestinal panel, and an STD panel.

Post a Comment

Previous Post Next Post

Contact Form